These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16224458)

  • 1. Why do we have so few effective drugs for irritable bowel syndrome? A European perspective.
    Quigley EM
    Nat Clin Pract Gastroenterol Hepatol; 2005 Oct; 2(10):436-7. PubMed ID: 16224458
    [No Abstract]   [Full Text] [Related]  

  • 2. New perspectives in irritable bowel syndrome: introduction to part 2.
    Barbara G; Stanghellini V
    Dig Liver Dis; 2009 Dec; 41(12):843. PubMed ID: 19709936
    [No Abstract]   [Full Text] [Related]  

  • 3. Why postprandial abdominal bloating in patients with irritable bowel syndrome does not respond to prokinetics.
    Bortolotti M; Lugli A
    Am J Gastroenterol; 2009 Mar; 104(3):794. PubMed ID: 19209159
    [No Abstract]   [Full Text] [Related]  

  • 4. A review of irritable bowel syndrome and an update on therapeutic approaches.
    Bassett JT; Cash BD
    Expert Opin Pharmacother; 2008 May; 9(7):1129-43. PubMed ID: 18422471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irritable bowel syndrome: the burden and unmet needs in Europe.
    Quigley EM; Bytzer P; Jones R; Mearin F
    Dig Liver Dis; 2006 Oct; 38(10):717-23. PubMed ID: 16807154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial overgrowth as a cause of irritable bowel syndrome.
    Riordan SM; Kim R
    Curr Opin Gastroenterol; 2006 Nov; 22(6):669-73. PubMed ID: 17053447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into the pathogenesis and pathophysiology of irritable bowel syndrome.
    Ohman L; Simrén M
    Dig Liver Dis; 2007 Mar; 39(3):201-15. PubMed ID: 17267314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathogenesis of irritable bowel syndrome: current understanding].
    Basilisco G
    Recenti Prog Med; 2007 Nov; 98(11):543-7. PubMed ID: 18044402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there a role for probiotics in irritable bowel syndrome?
    Camilleri M
    Dig Liver Dis; 2006 Dec; 38 Suppl 2():S266-9. PubMed ID: 17259088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Irritable bowel syndrome].
    Schmulson M; Siu AG
    Rev Gastroenterol Mex; 2006 Aug; 71 Suppl 1():77-8. PubMed ID: 17037781
    [No Abstract]   [Full Text] [Related]  

  • 11. Linaclotide (Linzess) for constipation.
    Med Lett Drugs Ther; 2012 Nov; 54(1403):91-2. PubMed ID: 23183319
    [No Abstract]   [Full Text] [Related]  

  • 12. [Irritable bowel syndrome: moot points and unanswered questions].
    Sheptulin AA
    Klin Med (Mosk); 2005; 83(8):78-81. PubMed ID: 16218372
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of irritable bowel syndrome.
    Hadley SK; Gaarder SM
    Am Fam Physician; 2005 Dec; 72(12):2501-6. PubMed ID: 16370407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between irritable bowel syndrome and unstable thoracolumbar vertebrae].
    Qu LX
    Zhongguo Gu Shang; 2009 Jun; 22(6):456-7. PubMed ID: 19594048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment options for irritable bowel syndrome.
    Harmon HW
    Nurse Pract; 2007 Jul; 32(7):39-43. PubMed ID: 17595589
    [No Abstract]   [Full Text] [Related]  

  • 16. Sequelae of traveler's diarrhea: focus on postinfectious irritable bowel syndrome.
    Connor BA
    Clin Infect Dis; 2005 Dec; 41 Suppl 8():S577-86. PubMed ID: 16267722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuro-immune interactions in inflammatory bowel disease and irritable bowel syndrome: future therapeutic targets.
    Kraneveld AD; Rijnierse A; Nijkamp FP; Garssen J
    Eur J Pharmacol; 2008 May; 585(2-3):361-74. PubMed ID: 18417115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commentary on peripheral and central contributions to hyperalgesia in irritable bowel syndrome.
    Mayer EA
    J Pain; 2006 Aug; 7(8):539-41; discussion 542-3. PubMed ID: 16885009
    [No Abstract]   [Full Text] [Related]  

  • 19. The functional-organic dichotomy: postinfectious irritable bowel syndrome and inflammatory bowel disease-irritable bowel syndrome.
    Grover M; Herfarth H; Drossman DA
    Clin Gastroenterol Hepatol; 2009 Jan; 7(1):48-53. PubMed ID: 18848909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota.
    Kajander K; Myllyluoma E; Rajilić-Stojanović M; Kyrönpalo S; Rasmussen M; Järvenpää S; Zoetendal EG; de Vos WM; Vapaatalo H; Korpela R
    Aliment Pharmacol Ther; 2008 Jan; 27(1):48-57. PubMed ID: 17919270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.